National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Drug Information
    Posted: 04/13/2007    Updated: 08/10/2007
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Related pages
Drug Information Summaries

Approval Process for New Cancer Treatments

Access to Investigational Drugs: Q & A
Fluorouracil

This page contains brief information about fluorouracil and a collection of links to more information from the National Cancer Institute (NCI), the Food and Drug Administration (FDA), and the National Library of Medicine (NLM).

US Brand Name(s):Adrucil
Efudex
Fluoroplex
FDA Approved:Yes

Fluorouracil is approved by the Food and Drug Administration (FDA) for palliative treatment of the following:

Fluorouracil is approved to be used with other drugs to treat:

Fluorouracil is also approved to be used by itself as a topical treatment for the following:

Fluorouracil is also called "5-FU". In addition to the uses that have been approved by the FDA, fluorouracil is sometimes used alone or with other drugs to treat other types of cancer. Fluorouracil also continues to be studied in the treatment of many types of cancer.

Information from the NCI

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trial Results: Chemotherapy Before Surgery May Increase Survival in Stomach Cancer (07/09/2007) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Patients With Esophageal Cancer May Be Able to Avoid Surgery (04/16/2007) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Chemotherapy Delays Recurrence of Liver Metastases from Colorectal Cancer (12/06/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Capecitabine an Alternative for Colon Cancer (07/27/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Docetaxel Combination for Node-Positive Breast Cancer (06/28/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Docetaxel Improves Survival in Stomach Cancer (05/15/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Docetaxel Extends Survival in Head and Neck Cancer (06/05/2004) - Important clinical trial results for this drug, background information, and how the trial was done.

Bevacizumab for Metastatic Colorectal Cancer (06/10/2003) - Information from the NCI Press Office about this drug.

100 Years of Advances Against Cancer - 1960s (03/26/2004) - Information about the use of this drug to treat cancer.

Information from the NLM

MedlinePlus Information on Fluorouracil - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

MedlinePlus Information on Topical Fluorouracil - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials

Clinical Trials for Fluorouracil - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.


Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov